Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Vigano', T. Rubino, G. Chiara, I. Ascari, Paola Massi, D. Parolaro (2003)
μ opioid receptor signaling in morphine sensitizationNeuroscience, 117
M. Ellgren, S. Spano, Y. Hurd (2007)
Adolescent Cannabis Exposure Alters Opiate Intake and Opioid Limbic Neuronal Populations in Adult RatsNeuropsychopharmacology, 32
J. Corchero, J. Oliva, C. Garcı́a-Lecumberri, Sonsoles Martı́n, E. Ambrosio, J. Manzanares (2004)
Repeated administration with δ9- tetrahydrocannabinol regulates µ-opioid receptor density in the rat brainJournal of Psychopharmacology, 18
L. Fattore, M. Spano, G. Cossu, S. Deiana, W. Fratta (2003)
Cannabinoid mechanism in reinstatement of heroin‐seeking after a long period of abstinence in ratsEuropean Journal of Neuroscience, 17
C. Maher, J. Eisenach, H. Pan, R. Xiao, S. Childers (2001)
Chronic intrathecal morphine administration produces homologous mu receptor/G-protein desensitization specifically in spinal cordBrain Research, 895
T. Rubino, D. Vigano', P. Massi, M. Spinello, E. Zagato, G. Giagnoni, D. Parolaro (2000)
Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions.Neuropharmacology, 39 7
Z. Justinova, G. Tanda, P. Munzar, S. Goldberg (2004)
The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeysPsychopharmacology, 173
J. Romero, E. Garcı́a-Palomero, J. Castro, L. Garcı́a-Gil, J. Ramos, J. Fernández-Ruiz (1997)
Effects of chronic exposure to Δ9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regionsMolecular Brain Research, 46
D. Braida, Morena Pozzi, R. Cavallini, M. Sala (2001)
Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid systemNeuroscience, 104
Jose Rodriguez, K. Mackie, V. Pickel (2001)
Ultrastructural Localization of the CB1 Cannabinoid Receptor in μ-Opioid Receptor Patches of the Rat Caudate Putamen NucleusThe Journal of Neuroscience, 21
M. Spano, M. Ellgren, Xiuzhe Wang, Y. Hurd (2007)
Prenatal Cannabis Exposure Increases Heroin Seeking with Allostatic Changes in Limbic Enkephalin Systems in AdulthoodBiological Psychiatry, 61
Amarendhra Kumar, M. Haney, T. Becker, M. Thompson, R. Kream, K. Miczek (1990)
Effect of early exposure to δ-9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brainBrain Research, 525
E. Jacobs, A. Smit, T. Vries, A. Schoffelmeer (2003)
Neuroadaptive effects of active versus passive drug administration in addiction research.Trends in pharmacological sciences, 24 11
L. Brady, M. Herkenham, J. Long, R. Rothman (1989)
Chronic morphine increases μ-opiate receptor binding in rat brain: a quantitative autoradiographic studyBrain Research, 477
J. Romero, F. Berrendero, L. Garcı́a-Gil, J. Ramos, J. Fernández-Ruiz (1998)
Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPγS binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to Δ9-tetrahydrocannabinolJournal of Molecular Neuroscience, 11
L. Fattore, G. Cossu, Cristina Martellotta, W. Fratta (2001)
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in ratsPsychopharmacology, 156
D. Selley, E. Nestler, C. Breivogel, S. Childers (1997)
Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatmentBrain Research, 746
G. Cossu, C. Ledent, L. Fattore, A. Imperato, G. Böhme, M. Parmentier, W. Fratta (2001)
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuseBehavioural Brain Research, 118
T. Rubino, L. Tizzoni, D. Vigano', P. Massi, D. Parolaro (1997)
Modulation of rat brain cannabinoid receptors after chronic morphine treatmentNeuroReport, 8
J. Henningfield, C. Cohen, S. Heishman (1991)
Drug self-administration methods in abuse liability evaluation.British journal of addiction, 86 12
M. Davis, T. Akera, T. Brody (1979)
Reduction of opiate binding to brainstem slices associated with the development of tolerance to morphine in rats.The Journal of pharmacology and experimental therapeutics, 211 1
T. Rubino, D. Vigano', B. Costa, M. Colleoni, D. Parolaro (2000)
Loss of Cannabinoid‐Stimulated Guanosine 5′‐O‐(3‐[35S]Thiotriphosphate) Binding Without Receptor Down‐Regulation in Brain Regions of Anandamide‐Tolerant RatsJournal of Neurochemistry, 75
L. Fattore, S. Spano, G. Cossu, S. Deiana, P. Fadda, W. Fratta (2004)
Cannabinoid Cb 1 Antagonist Sr 141716a Attenuates Reinstatement of Heroin Self-administration in Heroin-abstinent Rats
D. Vigano', M. Valenti, Maria Cascio, V. Marzo, D. Parolaro, T. Rubino (2004)
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphineEuropean Journal of Neuroscience, 20
Steven Childers, Rabi Simantov, Solomon Snyder (1977)
Enkephalin: radioimmunoassay and radioreceptor assay in morphine dependent rats.European journal of pharmacology, 46 3
T. Vries, J. Homberg, R. Binnekade, H. Raasø, A. Schoffelmeer (2003)
Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in ratsPsychopharmacology, 168
C. Breivogel, S. Childers, S. Deadwyler, R. Hampson, L. Vogt, L. Sim‐Selley (1999)
Chronic ▵9‐Tetrahydrocannabinol Treatment Produces a Time‐Dependent Loss of Cannabinoid Receptors and Cannabinoid Receptor‐Activated G Proteins in Rat BrainJournal of Neurochemistry, 73
L. Sim, R. Hampson, S. Deadwyler, S. Childers (1996)
Effects of Chronic Treatment with Δ9-Tetrahydrocannabinol on Cannabinoid-Stimulated [35S]GTPγS Autoradiography in Rat BrainThe Journal of Neuroscience, 16
L. Sim‐Selley, D. Selley, L. Vogt, S. Childers, T. Martin (2000)
Chronic Heroin Self-Administration Desensitizes μ Opioid Receptor-Activated G-Proteins in Specific Regions of Rat BrainThe Journal of Neuroscience, 20
M. Bernstein, S. Welch (1998)
mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance.Brain research. Molecular brain research, 55 2
D. Vigano', T. Rubino, A. Vaccani, Silvia Bianchessi, P. Marmorato, Chiara Castiglioni, D. Parolaro (2005)
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systemsPsychopharmacology, 182
G. Paxinos, Charles Watson (1983)
The Rat Brain in Stereotaxic Coordinates
L. Fattore, M. Spano, S. Deiana, V. Melis, G. Cossu, P. Fadda, W. Fratta (2007)
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectivesBrain Research Reviews, 53
L. Luttrell, R. Lefkowitz (2002)
The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals.Journal of cell science, 115 Pt 3
J. Manzanares, J. Corchero, J. Romero, J. Fernández-Ruiz, J. Ramos, J. Fuentes (1999)
Pharmacological and biochemical interactions between opioids and cannabinoids.Trends in pharmacological sciences, 20 7
M. Kumar, V. Patel, W. Millard (1984)
Effect of chronic administration of delta 9-tetrahydrocannabinol on the endogenous opioid peptide and catecholamine levels in the diencephalon and plasma of the rat.Substance and alcohol actions/misuse, 5 4
L. Sim, D. Selley, S. Dworkin, S. Childers (1996)
Effects of chronic morphine administration on mu opioid receptor- stimulated [35S]GTPgammaS autoradiography in rat brain, 16
P. Fadda, M. Scherma, M. Spano, P. Salis, V. Melis, L. Fattore, W. Fratta (2006)
Cannabinoid self-administration increases dopamine release in the nucleus accumbensNeuroReport, 17
Y. Cordeaux, S. Hill (2002)
Mechanisms of Cross-Talk between G-Protein-Coupled ReceptorsNeurosignals, 11
Fattore (2002)
Functional interaction between cannabinoids and opioids in animal models of drug addictionProceedings of the ‘Frontiers in Addiction Research’ NIDA Symposium Satellite at the SfN Meeting, 1-2 November 2002, Orlando (USA).
D. Vigano', M. Cascio, T. Rubino, F. Fezza, A. Vaccani, V. Marzo, D. Parolaro (2003)
Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat BrainNeuropsychopharmacology, 28
T. Rubino, D. Vigano', P. Massi, D. Parolaro (2000)
Changes in the Cannabinoid Receptor Binding, G Protein Coupling, and Cyclic AMP Cascade in the CNS of Rats Tolerant to and Dependent on the Synthetic Cannabinoid Compound CP55,940Journal of Neurochemistry, 75
J. Corchero, J. Oliva, C. Garcı́a-Lecumberri, Sonsoles Martı́n, E. Ambrosio, J. Manzanares (2004)
Repeated administration with Delta9-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain.Journal of psychopharmacology, 18 1
E. Nestler (2004)
Molecular mechanisms of drug addictionNeuropharmacology, 47
J. Manzanares, J. Corchero, J. Romero, J. Fernández-Ruiz, J. Ramos, J. Fuentes (1998)
Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain.Brain research. Molecular brain research, 55 1
D. Selley, L. Sim, Ruoyo Xiao, Qixu Liu, S. Childers (1997)
mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.Molecular pharmacology, 51 1
Malini Singh, A. Verty, I. McGregor, P. Mallet (2004)
A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphineBrain Research, 1026
M. Navarro, M. Carrera, W. Fratta, O. Valverde, G. Cossu, L. Fattore, J. Chowen, R. Gómez, I. Arco, M. Villanúa, R. Maldonado, G. Koob, F. Fonseca (2001)
Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-AdministrationThe Journal of Neuroscience, 21
C. Ledent, O. Valverde, G. Cossu, F. Petitet, J. Aubert, F. Beslot, G. Böhme, A. Imperato, T. Pedrazzini, B. Roques, G. Vassart, W. Fratta, M. Parmentier (1999)
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.Science, 283 5400
C. Manzanedo, M. Aguilar, M. Rodríguez-Arias, M. Navarro, J. Miñarro (2004)
Cannabinoid agonist-induced sensitisation to morphine place preference in miceNeuroReport, 15
S. Deiana, L. Fattore, M. Spano, G. Cossu, Emanuele Porcu, P. Fadda, W. Fratta (2007)
Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in ratsNeuropharmacology, 52
D. Braida, Morena Pozzi, D. Parolaro, M. Sala (2001)
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system.European journal of pharmacology, 413 2-3
F. Fan, Q. Tao, M. Abood, B. Martin (1996)
Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant miceBrain Research, 706
F. Noble, B. Cox (1996)
Differential desensitization of μ‐ and δ‐ opioid receptors in selected neural pathways following chronic morphine treatmentBritish Journal of Pharmacology, 117
L. Fattore, G. Cossu, M. Spano, S. Deiana, P. Fadda, M. Scherma, W. Fratta (2004)
Cannabinoids and reward: interactions with the opioid system.Critical reviews in neurobiology, 16 1-2
F. Noble, B. Cox (1996)
Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.British journal of pharmacology, 117 1
G. Cabral (2001)
Marijuana and Cannabinoids, 1
(1990)
Effect of early exposure to delta-9-tetrahydrocannabinol
L. Fattore, S. Deiana, S. Spano, G. Cossu, P. Fadda, M. Scherma, W. Fratta (2005)
Endocannabinoid system and opioid addiction: Behavioural aspectsPharmacology Biochemistry and Behavior, 81
L. Fattore, S. Spano, G. Cossu, S. Deiana, P. Fadda, W. Fratta (2005)
Cannabinoid CB1 antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent ratsNeuropharmacology, 48
L. Sim, R. Hampson, S. Deadwyler, S. Childers (1996)
Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.The Journal of neuroscience : the official journal of the Society for Neuroscience, 16 24
M. Spano, L. Fattore, G. Cossu, S. Deiana, P. Fadda, W. Fratta (2004)
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid‐seeking behaviour in the ratBritish Journal of Pharmacology, 143
V. Pickel, J. Chan, ThomasL Kash, J. Rodríguez, K. Mackie (2004)
Compartment-specific localization of cannabinoid 1 (CB1) and μ-opioid receptors in rat nucleus accumbensNeuroscience, 127
J. Dean, S. George, G. Wassink, A. Gunn, L. Bennet (2006)
Suppression of post-hypoxic-ischemic EEG transients with dizocilpine is associated with partial striatal protection in the preterm fetal sheepNeuropharmacology, 50
C. Lupica, A. Riegel, A. Hoffman (2004)
Marijuana and cannabinoid regulation of brain reward circuitsBritish Journal of Pharmacology, 143
C. O'brien, E. Gardner (2005)
Critical assessment of how to study addiction and its treatment: human and non-human animal models.Pharmacology & therapeutics, 108 1
Spano Spano, Ellgren Ellgren, Wang Wang, Hurd Hurd (2006)
Prenatal cannabis exposure increases heroin seeking in adults with allostatic changes in limbic enkephalin systemsBiol. Psych.
Nestler (1992)
Molecular mechanisms of drug addictionJ. Neurosci., 12
D. Parolaro, D. Vigano', T. Rubino (2005)
Endocannabinoids and drug dependence.Current drug targets. CNS and neurological disorders, 4 6
D. Vigano', T. Rubino, G. Chiara, I. Ascari, P. Massi, D. Parolaro (2003)
Mu opioid receptor signaling in morphine sensitization.Neuroscience, 117 4
M. Solinas, L. Panlilio, K. Antoniou, L. Pappas, S. Goldberg (2003)
The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio Schedules of Drug Self-Administration in RatsJournal of Pharmacology and Experimental Therapeutics, 306
T. Rubino, D. Vigano', P. Massi, M. Spinello, E. Zagato, G. Giagnoni, D. Parolaro (2000)
Chronic Δ-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regionsNeuropharmacology, 39
C. Maher, T. Martin, S. Childers (2005)
Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration.Life sciences, 77 10
This study examines the effect of intravenous self‐administration (SA) of either heroin or the cannabinoid receptor agonist WIN 55,212‐2 on levels and functionality of µ‐opioid (MOR) and CB1‐cannabinoid receptors (CB1R) in reward‐related brain areas, such as the prefrontal cortex (PFC), nucleus accumbens (NAc), caudate putamen (CP), hippocampus (Hippo), amygdala (Amy), hypothalamus (Hypo) and ventral tegmental area (VTA). (3H)DAMGO and (3H)CP‐55,940 autoradiography and agonist‐stimulated (35S)GTPγS binding were performed on brain sections of rats firmly self‐administering heroin or WIN 55,212‐2. Animals failing to acquire heroin or cannabinoid SA behaviour as well as drug‐naïve animals never exposed to experimental apparatus or procedure (home‐control group) were used as controls. With respect to control groups, which displayed very similar values, rats SA heroin showed increased MOR binding in the NAc (+174%), CP (+165%), Hippo (+121%), VTA (+175%), an enhanced CB1R density localized in the Amy (+147%) and VTA (+37%), and a widespread increased CB1 receptor functionality in the PFC (+95%), NAc (+313%), CP (+265%), Hippo (+38%), Amy (+221%). In turn, cannabinoid SA differently modulates CB1R binding in the Amy (+47%), Hypo (+94%), Hippo (−23%), VTA (−15%), and increases MOR levels (PFC: +124%; NAc: +68%; CP: +80%; Hippo: +73%; Amy: +99%) and efficiency (Hippo: +518%; Amy: +173%; Hypo: +188%). These findings suggest that voluntary chronic intake of opioids or cannabinoids induces reciprocal but differential regulation of MORs and CB1Rs density and activity in brain structures underlying drug‐taking and drug‐seeking behaviour, which could represent long‐term neuroadaptations contributing to the development of drug addiction and dependence.
European Journal of Neuroscience – Wiley
Published: Apr 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.